CorMedix CRMD Product sales, net — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's product sales, net — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CorMedix's product sales, net — total revenue?
- CorMedix (CRMD) reported product sales, net — total revenue of $121.92M in Q1 2026.
- How has CorMedix's product sales, net — total revenue changed year-over-year?
- CorMedix's product sales, net — total revenue increased by 211.9% year-over-year, from $39.08M to $121.92M.
- What does product sales, net — total revenue mean?
- This metric represents the total revenue generated from the commercial sale of pharmaceutical products after accounting for returns, allowances, and rebates. It serves as a primary indicator of market adoption and commercial success for the company's therapeutic portfolio. Tracking this figure allows investors to evaluate the growth trajectory and revenue-generating capacity of the company's core product offerings.